INVO Fertility (IVF) Amortizatization of Intangibles (2012 - 2025)
INVO Fertility's (IVF) quarterly Amortizatization of Intangibles came in at $1736.0 in Q3 2025, down 99.07% year-on-year from $186649.0 in Q3 2024, and down 96.04% on a QoQ basis from $43853.0 in Q2 2025.
INVO Fertility (IVF) Amortizatization of Intangibles (2012 - 2025) Analysis & Trends
INVO Fertility (IVF) has 11 years of Amortizatization of Intangibles data on file, last reported at $1736.0 in Q3 2025.
- On a quarterly basis, Amortizatization of Intangibles fell 99.07% year-over-year to $1736.0 in Q3 2025; TTM through Sep 2025 was $219268.0, a 65.93% decrease from a year earlier, with the FY2024 full-year figure at $622283.0, down 13.59% from the prior year.
- Amortizatization of Intangibles for Q3 2025 stood at $1736.0, down from $43853.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for IVF reached as high as $860155.0 in Q1 2021 and fell as low as $1736.0 in Q3 2025.
- Historically, Amortizatization of Intangibles has averaged $160539.6 across 5 years, with a median of $102953.5 in 2023.
- Across the five-year window, Amortizatization of Intangibles surged 15457.15% in 2021 and plunged 99.07% in 2025, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $173351.0 in 2021, then tumbled by 69.63% to $52644.0 in 2022, then soared by 104.9% to $107869.0 in 2023, then slipped by 19.7% to $86624.0 in 2024, then tumbled by 98.0% to $1736.0 in 2025.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $1736.0 in Q3 2025, $43853.0 in Q2 2025, and $87055.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | INVO Fertility | 1.54 Mn | -3.36 Mn | 732,978.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,736.00 |
| Sep 30, 2025 | 1,736.00 |
| Jun 30, 2025 | 43,853.00 |
| Jun 30, 2025 | 43,853.00 |
| Mar 31, 2025 | 87,055.00 |
| Mar 31, 2025 | 87,055.00 |
| Dec 31, 2024 | 86,624.00 |
| Dec 31, 2024 | 86,624.00 |
| Sep 30, 2024 | 186,649.00 |
| Sep 30, 2024 | 186,649.00 |
| Jun 30, 2024 | 250,972.00 |
| Jun 30, 2024 | 250,972.00 |
| Mar 31, 2024 | 98,038.00 |
| Mar 31, 2024 | 98,038.00 |
| Dec 31, 2023 | 107,869.00 |
| Dec 31, 2023 | 107,869.00 |
| Sep 30, 2023 | 311,161.00 |
| Sep 30, 2023 | 311,161.00 |
| Jun 30, 2023 | 122,718.00 |
| Jun 30, 2023 | 122,718.00 |